International survey of treatment practices for atopic dermatitis in pregnant and breastfeeding women: Physician perspectives
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2025
DOI: 10.1111/ddg.15728 ↗Kurz gefasst
Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2025. Verfasst von Manuel P Pereira und 34 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berl…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Breast Feeding, Practice Patterns, Physicians', Pregnancy Complications. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Hebammenwesen und Geburtshilfe, Stillen
Abstract (Originalsprache)
Background and Objectives Systemic treatment of pregnant/breastfeeding atopic dermatitis (AD) patients is challenging due to limited safety data. We explored treatment practices with systemic agents, including the guideline‐recommended cyclosporine as the first systemic choice as well as emerging therapies, in this vulnerable population. Patients and Methods The Global Allergy and Asthma Excellence Network (GA 2 LEN) ADCARE initiative collected data from physicians worldwide who treat pregnant women with AD. Physicians completed an electronic questionnaire on the use of systemic agents in pregnant/breastfeeding AD patients.
Results
103 physicians from 32 countries completed the survey, primarily dermatologists (n = 48) or allergologists (n = 43). Antihistamines were the systemic drug most often considered to be used during pregnancy/breastfeeding (n = 73/81, 90.1%), with fewer physicians considering the use of systemic agents for the first trimester compared to later stages of pregnancy. For acute flares, systemic corticosteroids (n = 34/80, 42.5%) were preferred, followed by biologics and antihistamines (each n = 15/80, 18.8%). Although the guideline‐recommended cyclosporine is sometimes considered for AD during pregnancy (n = 38/81, 46.9%), it was rarely considered as the preferred drug by physicians (n = 1/80, 1.25%).
Conclusions
Our study shows a misalignment between guideline recommendations and prescription patterns and highlights an unmet need for knowing and using the existing recommendations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
- GA2LEN, Global Allergy and Asthma Excellence Network, Berlin, Germany.
- Bahcesehir University School of Medicine, Department of Dermatology, Istanbul, Turkey.
- University of Cincinnati College of Medicine, Division of Rheumatology, Allergy and Immunology, Partner of Bernstein Allergy Group and Bernstein Clinical Research Center.
- Allergy and Immunology Research Center, Federal University of Pernambuco, Recife, Brazil.
ORCID-Profile: Margitta Worm
Zitieren
APA
Pereira, M. P., Stevanovic, K., Kocatürk, E., Meesch, C., van Hofman, I., Vaswani, P. S., Bernstein, J. A., Bruscky, D., Chong-Neto, H. J., Chu, C. Y., Criado, R. F. J., Ensina, L. F., Giménez-Arnau, A. M., Godse, K., Gotua, M., Gregoriou, S., Kulthanan, K., Mortz, C. G., Mitrevska, N. T., …, & Zuberbier, T. (2025). International survey of treatment practices for atopic dermatitis in pregnant and breastfeeding women: Physician perspectives. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15728
Vancouver
Pereira MP, Stevanovic K, Kocatürk E, Meesch C, van Hofman I, Vaswani PS, et al. International survey of treatment practices for atopic dermatitis in pregnant and breastfeeding women: Physician perspectives. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2025. doi:10.1111/ddg.15728
BibTeX
@article{Pereira2025,
author = {Pereira, Manuel P and Stevanovic, Katarina and Kocatürk, Emek and Meesch, Cathrin and van Hofman, Ingrid and Vaswani, Prema S and Bernstein, Jonathan A and Bruscky, Dayanne and Chong-Neto, Herberto J and Chu, Chia-Yu and Criado, Roberta Fachini Jardim and Ensina, Luis Felipe and Giménez-Arnau, Ana M and Godse, Kiran and Gotua, Maia and Gregoriou, Stamatios and Kulthanan, Kanokvalai and Mortz, Charlotte G and Mitrevska, Natasa Teovska and Özkaya, Esen and Pudasaini, Prajwal and Felix, Mara Morelo Rocha and Pérez, Catalina Rincón and Parisi, Claudio Alberto Salvador and Ramón, Gonzalo N and Vakirlis, Efstratios and Zhao, Zuotao and Beck, Lisa A and de Bruin-Weller, Marjolein and Cork, Michael and Katoh, Norito and Werfel, Thomas and Worm, Margitta and Wollenberg, Andreas and Zuberbier, Torsten},
title = {International survey of treatment practices for atopic dermatitis in pregnant and breastfeeding women: Physician perspectives},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2025},
doi = {10.1111/ddg.15728}
}
EUVIMED